We are live on ! Find out more
11A

10-15 Associates Portfolio holdings

AUM $516M Turnover 13.73%
1-Year Est. Return 7.62%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+7.62%
3 Year Est. Return
+32.98%
5 Year Est. Return
+79.47%
10 Year Est. Return
–
AUM
$396M
AUM Growth
+$40.1M
Cap. Flow
+$22.9M
Cap. Flow %
5.79%
Top 10 Hldgs %
35.58%
Holding
107
New
11
Increased
49
Reduced
33
Closed
9
Avg Time Held
2.6 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
RIO icon
Rio Tinto
RIO
+$9.57M
2
CSCO icon
Cisco
CSCO
+$8.31M
3
EPD icon
Enterprise Products Partners
EPD
+$5.52M
4
BAC icon
Bank of America
BAC
+$2.37M
5
ADI icon
Analog Devices
ADI
+$2.31M

Sector Composition

Rank Sector Weight
1 Financials 16.42%
2 Healthcare 13.92%
3 Technology 12.73%
4 Energy 11.89%
5 Materials 11.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VZ icon
1
Verizon
VZ
$184B
$29.5M 7.46%
596,766
+8,292
+1% +$390K
2013 Q2
17 quarters
JNJ icon
2
Johnson & Johnson
JNJ
$610B
$14.1M 3.56%
108,284
-701
-0.6% -$92.9K
2013 Q2
17 quarters
JPM icon
3
JPMorgan Chase
JPM
$891B
$13.7M 3.46%
143,389
-16,638
-10% -$1.53M
2013 Q2
17 quarters
PG icon
4
Procter & Gamble
PG
$365B
$13.1M 3.31%
144,118
+8,759
+6% +$797K
2015 Q2
9 quarters
INTC icon
5
Intel
INTC
$504B
$12.3M 3.11%
322,862
-762
-0.2% -$27.1K
2016 Q1
6 quarters
WDC icon
6
Western Digital
WDC
$133B
$12.3M 3.1%
187,657
+209
+0.1% +$13.9K
2015 Q2
9 quarters
PFE icon
7
Pfizer
PFE
$168B
$11.8M 2.97%
347,299
+14,788
+4% +$475K
2014 Q1
14 quarters
MET icon
8
MetLife
MET
$63.7B
$11.6M 2.93%
223,301
-13,293
-6% -$647K
2014 Q1
14 quarters
RDS.B
9
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$11.3M 2.84%
180,035
+8,743
+5% +$502K
2016 Q3
4 quarters
AXP icon
10
American Express
AXP
$212B
$11.3M 2.84%
124,429
+29
+0% +$2.49K
2015 Q1
10 quarters
QCOM icon
11
Qualcomm
QCOM
$191B
$11M 2.77%
211,522
+19,453
+10% +$1.03M
2013 Q2
17 quarters
LYB icon
12
LyondellBasell Industries
LYB
$20.2B
$11M 2.77%
110,630
-2,093
-2% -$188K
2016 Q3
4 quarters
GSK icon
13
GSK
GSK
$98.2B
$10.7M 2.7%
210,676
+18,442
+10% +$936K
2014 Q4
11 quarters
PNC icon
14
PNC Financial Services
PNC
$85.7B
$10.6M 2.68%
78,673
-81
-0.1% -$10.4K
2013 Q4
15 quarters
BA icon
15
Boeing
BA
$149B
$10.4M 2.64%
41,082
-4,296
-9% -$1M
2013 Q2
17 quarters
COP icon
16
ConocoPhillips
COP
$170B
$10.4M 2.62%
206,873
+16,509
+9% +$742K
2016 Q3
4 quarters
SLB icon
17
SLB Ltd
SLB
$71.8B
$10.3M 2.6%
147,302
+14,280
+11% +$944K
2013 Q2
17 quarters
AGU
18
DELISTED
Agrium
AGU
$9.98M 2.52%
93,124
+3,861
+4% +$385K
2014 Q3
12 quarters
KKR icon
19
KKR & Co
KKR
$78.7B
$9.78M 2.47%
481,237
+55,617
+13% +$1.06M
2015 Q1
10 quarters
RIO icon
20
Rio Tinto
RIO
$147B
$9.71M 2.45%
+205,834
New +$9.57M
2017 Q3
0 quarters
JCI icon
21
Johnson Controls International
JCI
$89.4B
$9.7M 2.45%
240,740
+36,150
+18% +$1.46M
2013 Q2
17 quarters
GE icon
22
GE Aerospace
GE
$324B
$9.26M 2.34%
79,874
+1,814
+2% +$219K
2013 Q2
17 quarters
CSCO icon
23
Cisco
CSCO
$433B
$8.77M 2.22%
+260,910
New +$8.31M
2017 Q3
0 quarters
MRK icon
24
Merck
MRK
$358B
$8.44M 2.13%
138,215
+20,200
+17% +$1.22M
2013 Q4
15 quarters
EPD icon
25
Enterprise Products Partners
EPD
$76.8B
$8.02M 2.03%
307,705
+208,920
+211% +$5.52M
2013 Q2
17 quarters

Similar funds

10-15 Associates's Q3 2017 Portfolio in Review

As of Q3 2017, 10-15 Associates held 107 positions worth $396M, up 11% from $356M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

10-15 Associates deployed $22.9M of net new capital in Q3 2017, opening 11 new positions and adding to 49 existing holdings. Its largest new stake was Rio Tinto: 205,834 shares worth $9.71M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $1.53M trimmed.

  • 10-15 Associates's largest Q3 2017 buy was Rio Tinto: 205,834 shares worth $9.71M.
  • 10-15 Associates added most to Enterprise Products Partners in Q3 2017, an estimated $5.52M increase.
  • 10-15 Associates's biggest Q3 2017 reduction was JPMorgan Chase, cutting an estimated $1.53M.
  • 10-15 Associates fully exited Masco in Q3 2017, selling an estimated $8.59M.
  • 10-15 Associates's ten largest holdings make up 36% of its $396M portfolio in Q3 2017.
  • 10-15 Associates opened 11 new positions and closed 9 in Q3 2017.
  • 10-15 Associates's portfolio value rose 11% quarter-over-quarter to $396M.

Based on 10-15 Associates's 13F filing for Q3 2017, filed 15 Nov 2017.